# Lapatinib and Cetuximab in Patients With Solid Tumors

> **NCT01184482** · PHASE1 · COMPLETED · sponsor: **Georgetown University** · enrollment: 22 (actual)

## Conditions studied

- Colorectal Cancer
- Lung Cancer
- Head and Neck Cancer

## Interventions

- **DRUG:** cetuximab and lapatinib

## Key facts

- **NCT ID:** NCT01184482
- **Lead sponsor:** Georgetown University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2013-06
- **Final completion:** 2013-09
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2013-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01184482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01184482, "Lapatinib and Cetuximab in Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01184482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*